Cefovecin
An antibiotic used in veterinary medicine
| Cefovecin | |
|---|---|
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
Cefovecin is a broad-spectrum antibiotic belonging to the cephalosporin class, specifically designed for use in veterinary medicine. It is commonly used to treat bacterial infections in dogs and cats.
Pharmacology
Cefovecin is a third-generation cephalosporin, which means it has a broad spectrum of activity against both Gram-positive and Gram-negative bacteria. It works by inhibiting bacterial cell wall synthesis, leading to cell lysis and death.
Administration and Dosage
Cefovecin is administered via subcutaneous injection, typically at a dose of 8 mg/kg. Its long half-life allows for a single injection to provide therapeutic levels for up to 14 days, making it convenient for treating infections in animals that are difficult to medicate orally.
Indications
Cefovecin is indicated for the treatment of skin infections, urinary tract infections, and soft tissue infections in dogs and cats. It is particularly useful in cases where compliance with oral medication is a concern.
Side Effects
Common side effects of cefovecin include mild gastrointestinal upset, such as vomiting and diarrhea. In rare cases, allergic reactions may occur, which can manifest as anaphylaxis or skin reactions.
Mechanism of Action
Cefovecin binds to penicillin-binding proteins (PBPs) located inside the bacterial cell wall, disrupting the synthesis of peptidoglycan, an essential component of the bacterial cell wall. This leads to the weakening of the cell wall and ultimately causes bacterial cell death.
Resistance
As with other antibiotics, the use of cefovecin can lead to the development of antibiotic resistance. It is important to use this medication judiciously and only when prescribed by a veterinarian.
Related pages
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD